FSMDX
Price
$43.84
Change
+$0.23 (+0.53%)
Updated
Aug 19 closing price
Net Assets
52.09B
TMAPX
Price
$58.61
Change
+$0.45 (+0.77%)
Updated
Aug 19 closing price
Net Assets
3.51B
Interact to see
Advertisement

FSMDX vs TMAPX

FSMDX vs TMAPX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. TMAPX commentary
Aug 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and TMAPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 52.1B vs. TMAPX (3.51B). FSMDX pays higher dividends than TMAPX: FSMDX (0.76) vs TMAPX (0.01). FSMDX was incepted earlier than TMAPX: FSMDX (15 years) vs TMAPX (19 years). TMAPX (1.18) is less costly to investors than FSMDX (0.03). FSMDX is a more actively managed with annual turnover of: 15.00 vs. TMAPX (12.00). FSMDX has a lower initial minimum investment than TMAPX: FSMDX (0) vs TMAPX (2500). FSMDX annual gain was more profitable for investors over the last year : 21.35 vs. TMAPX (4.54). FSMDX return over 5 years is better than : 47.59 vs. TMAPX (23.26).
FSMDXTMAPXFSMDX / TMAPX
Total Expense Ratio0.031.182%
Annual Report Gross Expense Ratio0.031.182%
Fund Existence15 years19 years-
Gain YTD18.0884.698385%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets52.1B3.51B1,486%
Annual Yield % from dividends0.760.015,745%
Returns for 1 year21.354.54470%
Returns for 3 years63.6023.83267%
Returns for 5 years47.5923.26205%
Returns for 10 years168.64120.80140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNTA1.220.05
+4.27%
Genenta Science SpA
STOK33.030.89
+2.77%
Stoke Therapeutics
FCNCO20.700.17
+0.83%
First Citizens BancShares
ENSG182.49N/A
N/A
Ensign Group (The)
CYH2.92-0.06
-2.01%
Community Health Systems